Concord Biotech Limited IPO (CONCORDBIO)
Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.
Brokerage-free equity & mutual fund investments
Trade with Zerodha's Kite platform and tools.
- Zero brokerage on equity delivery
- ₹20 flat for intraday, F&O, currency and commodity*
- Free direct mutual fund investing
Flat ₹20 per order, every segment
Trade stocks, derivatives and more on 5paisa's platform.
- ₹20 flat for delivery, intraday and F&O
- Free account opening
- Listed on NSE and BSE
Frequently asked questions
What is the price band for the Concord Biotech Limited IPO?
The Concord Biotech Limited IPO price band is Rs.705 to Rs.741 per share.
When does the Concord Biotech Limited IPO open and close?
Bidding opens 4 August 2023 and closes 8 August 2023.
Is the Concord Biotech Limited IPO a mainboard or SME issue?
Concord Biotech Limited is a mainboard IPO, listing on NSE's main board.
When did the Concord Biotech Limited IPO list?
Concord Biotech Limited listed on 18 August 2023.
Does this page show the grey market premium (GMP) for Concord Biotech Limited?
No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.
Is investing in the Concord Biotech Limited IPO recommended by BrokerLens?
No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.